Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q4 2020
The quarterly LOR summary is produced by
Mitchell
Article
As Crises Linger, U.S. Hospitals Continue to Face Headwinds
This article is authored by guest blogger, Jill Harris, Senior Director, Network Development at Coventry, a part of Mitchell | Genex | Coventry
Workers' Comp
Article
A Shot in the Arm to Move Claims Forward During COVID
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
Mitchell
Article
COVID—A Year Later
How the World (May Be) Forever Changed by COVID-19 One year ago this week, our Company sent out the first set of employee notices to adop
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the